» Articles » PMID: 18235501

DBC1 is a Negative Regulator of SIRT1

Overview
Journal Nature
Specialty Science
Date 2008 Feb 1
PMID 18235501
Citations 310
Authors
Affiliations
Soon will be listed here.
Abstract

The NAD-dependent protein deacetylase Sir2 (silent information regulator 2) regulates lifespan in several organisms. SIRT1, the mammalian orthologue of yeast Sir2, participates in various cellular functions and possibly tumorigenesis. Whereas the cellular functions of SIRT1 have been extensively investigated, less is known about the regulation of SIRT1 activity. Here we show that Deleted in Breast Cancer-1 (DBC1), initially cloned from a region (8p21) homozygously deleted in breast cancers, forms a stable complex with SIRT1. DBC1 directly interacts with SIRT1 and inhibits SIRT1 activity in vitro and in vivo. Downregulation of DBC1 expression potentiates SIRT1-dependent inhibition of apoptosis induced by genotoxic stress. Our results shed new light on the regulation of SIRT1 and have important implications in understanding the molecular mechanism of ageing and cancer.

Citing Articles

A proteasome-dependent inhibition of SIRT-1 by the resveratrol analogue 4,4'-dihydroxy-stilbene.

Livraghi V, Mazza L, Chiappori F, Cardano M, Cazzalini O, Puglisi R J Tradit Complement Med. 2024; 14(5):534-543.

PMID: 39262665 PMC: 11384077. DOI: 10.1016/j.jtcme.2024.03.001.


Inhibitory protein-protein interactions of the SIRT1 deacetylase are choreographed by post-translational modification.

Krzysiak T, Choi Y, Kim Y, Yang Y, DeHaven C, Thompson L Protein Sci. 2024; 33(4):e4938.

PMID: 38533551 PMC: 10966392. DOI: 10.1002/pro.4938.


Current Trends in Sirtuin Activator and Inhibitor Development.

Bursch K, Goetz C, Smith B Molecules. 2024; 29(5).

PMID: 38474697 PMC: 10934002. DOI: 10.3390/molecules29051185.


The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPK.

Zhang T, Xu L, Guo X, Tao H, Liu Y, Liu X J Pharm Anal. 2024; 14(2):157-176.

PMID: 38464786 PMC: 10921247. DOI: 10.1016/j.jpha.2023.09.001.


SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity.

Kang J, Kim Y, Jang K, Won Moon H, Lee H, Lee S Exp Mol Med. 2024; 56(3):656-673.

PMID: 38443596 PMC: 10985095. DOI: 10.1038/s12276-024-01194-2.